How many institutional investors hold CAPR?

3 tracked institutional investors disclosed a position in CAPR (CAPRICOR THERAPEUTICS INC) in their most recent 13F filing.

Who is the largest institutional holder of CAPR?

Steve Cohen, Point72 Asset Management, holds the largest disclosed position in CAPR, valued at $55M.

Where does this CAPR ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

CAPR — CAPRICOR THERAPEUTICS INC

Name: CAPRICOR THERAPEUTICS INC (CAPR) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About CAPRICOR THERAPEUTICS INC (CAPR)

CAPRICOR THERAPEUTICS INC (CAPR) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Steve Cohen (Point72 Asset Management), valued at $55M. Across recent filings, tracked investors recorded 4 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in CAPR

100

/100

Strong Institutional Accumulation

Added / Increased4

Reduced0

Exited0

BearishBullish

Crowded Trade Score™

How many top investors track CAPR

/100

Emerging Interest

3investors

A small number of top investors own this.

UndiscoveredCrowded

151015+

CAPR Ownership Composition

How CAPRICOR THERAPEUTICS INC is held across tracked investor types, based on reported 13F positions.

Dominant Type

Other

69% of tracked value

Institutions

tracked investors

Total Reported

$79.6M

combined 13F value

Other68.6%
Hedge Funds31.4%

Other(2)

68.6%

Hedge Funds(1)

31.4%

Tracked investors reporting CAPR

Investor	Firm	Shares	Market value	% of portfolio	As of
Steve Cohen	Point72 Asset Management	821.2K	$25M	0.03%	Mar 31, 2026
Ken Griffin	Citadel Advisors	1.4M	$43.8M	0.01%	Mar 31, 2026
Izzy Englander	Millennium Management	356.4K	$10.8M	0.00%	Mar 31, 2026

Steve CohenMar 31, 2026
Point72 Asset Management
Shares
821.2K
Value
$25M
% Portfolio
0.03%
Ken GriffinMar 31, 2026
Citadel Advisors
Shares
1.4M
Value
$43.8M
% Portfolio
0.01%
Izzy EnglanderMar 31, 2026
Millennium Management
Shares
356.4K
Value
$10.8M
% Portfolio
0.00%

Recent activity

Investor	Action	Δ %	Current value	Filing date
Izzy Englander	New	—	$19.7M	Feb 17, 2026
Steve Cohen	New	—	$54.6M	Feb 17, 2026
Steve Cohen	New	—	$25M	May 15, 2026
Ken Griffin	New	—	$11.9M	Nov 14, 2025

Izzy Englander
New
$19.7MFeb 17, 2026
Steve Cohen
New
$54.6MFeb 17, 2026
Steve Cohen
New
$25MMay 15, 2026
Ken Griffin
New
$11.9MNov 14, 2025

Frequently asked questions

How many institutional investors hold CAPR?: 3 tracked institutional investors disclosed a position in CAPR (CAPRICOR THERAPEUTICS INC) in their most recent 13F filing.
Who is the largest institutional holder of CAPR?: Steve Cohen, Point72 Asset Management, holds the largest disclosed position in CAPR, valued at $55M.
Did institutional ownership of CAPR increase or decrease?: Across recent 13F filings, tracked investors recorded 4 new positions, 0 increased, 0 reduced, and 0 fully exited CAPR.
Where does this CAPR ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.